skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Nucleic acid recognizing Toll-like receptors as therapeutic targets: a focus on autoimmunity and cancer

Review

(2734) Views  (785) Full article downloads

Authors: Philipp Yu

Published Date August 2009 Volume 2009:2 Pages 19 - 28
DOI: http://dx.doi.org/10.2147/JRLCR.S4679

Philipp Yu

Institute for Immunology, Philipps-Universität-Marburg, Marburg, Germany

Abstract: The “trinity” of nucleic acid recognizing Toll-like receptors (TLRs) is the focus of intense research efforts. Among the plethora of pattern recognition receptors the ones that recognize RNA and DNA always seemed Janus-faced in their potential – dangerous, but also promising. Therefore manipulating TLR3, TLR7 and TLR9, which recognize dsRNA-, ssRNA and CpG-containing DNA, respectively, is a very attractive goal, because increasing evidence shows that both suppression or enhancement of the immune system might thereby be achieved. In this review we try to illustrate the current knowledge of the endosomal nucleic acid recognizing TLRs. We then want to extend our view beyond the pathogen recognizing capacity to their role in autoimmunity and cancer. Significant progress has been made in our understanding of the structure of TLRs, signaling pathways and ligand identity. The question of if and how we can translate this into new specific immunosuppressive drugs or anti-cancer adjuvants is discussed.

Keywords: Toll-like receptors, immunosuppressive drugs, anti-cancer adjuvants








Readers of this article also read:

Periosteoplasty for covering gingival recessions: Clinical results
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
NMDA-gated ion channel research and its therapeutic potentials in neurodegenerative diseases: a review
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Steroid response pattern and outcome of pediatric idiopathic nephrotic syndrome: a single-center experience in northwest Iran
Antioxidant oils and Salmonella enterica Typhimurium reduce tumor in an experimental model of hepatic metastasis
Specific mechanism of action of amisulpride in the treatment of schizophrenia and correlation with clinical response and tolerability
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Erratum